Stock MXCT MAXCYTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. MaxCyte, Inc.

Equities

MXCT

US57777K1060

Market Closed - London S.E.
Other stock markets
 11:35:06 2024-04-30 am EDT 		5-day change 1st Jan Change
295 GBX 0.00% Intraday chart for MaxCyte, Inc. -8.67% -16.31%
Apr. 02 MaxCyte inks deal with Be Bio; Orcadian firms farmout AN
Apr. 02 MaxCyte, Inc. Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BTIG Adjusts Price Target on MaxCyte to $8 From $10, Maintains Buy Rating
MT
Craig-Hallum Starts Coverage on MaxCyte with Buy Rating, $7 Price Target
MT
Interest Rate Worries, Jobs Outlook Leave Exchange-Traded Funds, Equity Futures Mixed Premarket Thursday
MT
BTIG Adjusts MaxCyte's Price Target to $11 From $10, Reiterates Buy Rating
MT
Stifel Nicolaus Adjusts Price Target for MaxCyte tp $16 From $18, Maintains Buy Rating
MT
FTSE Edges Lower, March Inflation Data Seen Securing Another BoE Rate Rise in May
DJ
FTSE Down, BOE's Inflation, Interest-Rate Outlook Key For Long-Dated Gilts
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MXCT Stock
  4. News MaxCyte, Inc.
  5. Analyst Reco.